The role of effective albumin in chronic liver disease

doi:10.16352/j.issn.1001-6325.2024.12.1707

Abstract

Abstract: Effective albumin refers to serum albumin with intact structure and function. In the course of chronic liver disease, some serum albumin loses its functional integrity through different post-translational modifications such as oxidation and glycosylation. Level of effective albumin is lower in patients with decompensated cirrhosis and is significantly correlated with patient survival, underscoring that they are more sensitive than total serum albumin in reflecting the actual state of liver function. In addition, effective albumin not only serves as a predictor, but also plays a key role in the treatment of chronic liver disease by improving albumin preparations and developing new therapeutics.

Key words: effective albumin, liver cirrhosis, liver failure, liver cancer

CLC Number:

R575.5

LIN Jun, LI Zepeng, YU Junying. The role of effective albumin in chronic liver disease[J]. Basic & Clinical Medicine, 2024, 44(12): 1707-1711.

References

[1]Griffin C, Agbim U, Ramani A, et al. Underestimation of cirrhosis-related mortality in the medicare eligible population, 1999-2018[J]. Clin Gastroenterol Hepatol, 2023, 21: 223-225.e3. doi: 10.1016/j.cgh.2021.10.036.
[2]Jalan R, Schnurr K, Mookerjee RP, et al. Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality[J]. Hepatol Baltim Md, 2009, 50: 555-564. doi: 10.1002/hep.22913.
[3]Wu N, Liu T, Tian M, et al. Albumin, an interesting and functionally diverse protein, varies from “native” to “effective”[J]. Mol Med Rep, 2024, 29: 24. doi: 10.3892/mmr.2023.13147.
[4]Liu B, Yasukawa K, Koid SS, et al. A rapid method for measuring serum oxidized albumin in a rat model of proteinuria and hypertension[J]. Sci Rep, 2019, 9: 8620. doi: 10.1038/s41598-019-45134-x.
[5]Jalan R, Bernardi M. Effective albumin concentration and cirrhosis mortality: from concept to reality[J]. J Hepatol, 2013, 59: 918-920. doi: 10.1016/j.jhep.2013.08.001.
[6]Wu D, Gucwa M, Czub MP, et al. Structural and biochemical characterisation of Co2+-binding sites on serum albumins and their interplay with fatty acids[J]. Chem Sci, 2023, 14: 6244-6258. doi: 10.1039/d3sc01723k.
[7]Paar M, Fengler VH, Reibnegger G, et al. Determina-tion of binding characteristics as a measure for effective albumin using different methods[J]. Biochim Biophys Acta Gen Subj, 2023, 1867: 130427. doi: 10.1016/j.bbagen.2023.130427.
[8]Klinkmann G, Waterstradt K, Klammt S, et al. Exploring albumin functionality assays: a pilot study on sepsis evaluation in intensive care medicine[J]. Int J Mol Sci, 2023, 24: 12551. doi: 10.3390/ijms241612551.
[9]孙立杰, 郝丹丹. 诱导肝星状细胞铁死亡治疗肝纤维化的研究进展[J]. 基础医学与临床, 2024, 44: 108-113.
[10]Baldassarre M, Naldi M, Zaccherini G, et al. Determination of effective albumin in patients with decompensated cirrhosis: clinical and prognostic implications[J]. Hepatol Baltim Md, 2021, 74: 2058-2073. doi: 10.1007/s12325-023-02430-3.
[11]Zheng X, Bai Z, Wang T, et al. Human albumin infusion for the management of liver cirrhosis and its complica-tions: an overview of major findings from meta-analyses[J]. Adv Ther, 2023, 40: 1494-1529. doi: 10.1007/s12325-023-02430-3.
[12]Caraceni P, Riggio O, Angeli P, et al. Long-term albumin administration in decompensated cirrhosis: an open-label randomised trial[J]. Lancet, 2018, 391: 2417-2429. doi: 10.1016/S0140-6736(18)30840-7.
[13]Bai Z, Wang L, Wang R, et al. Use of human albumin infusion in cirrhotic patients: a systematic review and meta-analysis of randomized controlled trials[J]. Hepatol Int, 2022, 16: 1468-1483. doi: 10.1007/s12072-022-10374-z.
[14]Solà E, Solé C, Simón-Talero M, et al. Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. a randomized placebo-controlled trial[J]. J Hepatol, 2018, 69: 1250-1259. doi: 10.1016/j.jhep.2018.08.006.
[15]Xu T, Liu W, Huang R. Can albumin reduce the mortality of patients with cirrhosis and ascites? a meta-analysis of randomized controlled trials[J]. Eur J Gastroenterol Hepatol, 2023, 35: 80-88. doi: 10.1097/MEG.0000000000002447.
[16]Plantier JL, Duretz V, Devos V, et al. Comparison of antioxidant properties of different therapeutic albumin preparations[J]. Biol J Int Assoc Biol Stand, 2016, 44: 226-233. doi: 10.1016/j.biologicals.2016.04.002.
[17]Miyamura S, Imafuku T, Anraku M, et al. Comparison of posttranslational modification and the functional impair-ment of human serum albumin in commercial preparations[J]. J Pharm Sci, 2016, 105: 1043-1049. doi: 10.1016/j.xphs.2015.12.015.
[18]Bañares R, Nevens F, Larsen FS, et al. Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the relief trial[J]. Hepatol Baltim Md, 2013, 57: 1153-1162. doi: 10.1002/hep.26185.
[19]Kreymann B, Seige M, Schweigart U, et al. Albumin dialysis: effective removal of copper in a patient with fulminant wilson disease and successful bridging to liver transplantation: a new possibility for the elimination of protein-bound toxins[J]. J Hepatol, 1999, 31: 1080-1085. doi: 10.1016/s0168-8278(99)80322-5.
[20]Chawla LS, Georgescu F, Abell B, et al. Modification of continuous venovenous hemodiafiltration with single-pass albumin dialysate allows for removal of serum bilirubin[J]. Am J Kidney Dis, 2005, 45: e51-e56. doi: 10.1053/j.ajkd.2004.11.023.
[21]Lei Q, Zhang Y, Ke C, et al. Value of the albumin-bilirubin score in the evaluation of hepatitis B virus-related acute-on-chronic liver failure, liver cirrhosis, and hepatocellular carcinoma[J]. Exp Ther Med, 2018, 15: 3074-3079. doi: 10.3892/etm.2018.5748.
[22]Sheng Y, Zeng Y, Luo W, et al. Predictive value of the prothrombin time-international normalized ratio to albumin ratio in the prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure[J]. Int J Gen Med, 2023, 16: 4565-4572. doi: 10.2147/IJGM.S434572.
[23]Lin H, Fan Y, Wieser A, et al. Albumin might attenuate bacteria-induced damage on kupffer cells for patients with chronic liver disease[J]. Cells, 2021, 10: 2298. doi: 10.3390/cells10092298.
[24]Duran-Güell M, Garrabou G, Flores-Costa R, et al. Essential role for albumin in preserving liver cells from TNFα-induced mitochondrial injury[J]. FASEB J, 2023, 37: e22817. doi: 10.1096/fj.202201526R.